Mollifeye (Chloramphenicol)

Chloramphenicol, the active ingredient in Mollifeye, is an antibiotic presented as an ophthalmic preparation for ocular use. It is employed to treat bacterial eye infections by inhibiting the growth of susceptible microorganisms in the conjunctiva, cornea, and surrounding ocular tissues.

GNH USA supplies Mollifeye as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with the product sourced from EU‑approved manufacturers. Our distribution network ensures consistent quality and regulatory compliance across regions.

Mollifeye (chloramphenicol) is used to treat bacterial infections of the eye and related ocular tissues.

- Bacterial conjunctivitis: reduces bacterial load and alleviates inflammation of the conjunctiva. - Bacterial keratitis: eradicates pathogenic bacteria in the cornea, promoting healing and preventing scarring. - Blepharitis: controls bacterial overgrowth on the eyelid margins, reducing redness and irritation.

Ophthalmic chloramphenicol may cause local and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Stinging or burning sensation on application. - Transient blurred vision. - Mild conjunctival redness.

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling. - Corneal epithelial toxicity or ulceration. - Systemic bone marrow suppression (aplastic anemia) in rare cases.

When using Mollifeye, several precautions should be observed to ensure safety and maintain product efficacy. - Allergy assessment: avoid use in patients with known hypersensitivity to chloramphenicol or any formulation components. - Contact lens use: discontinue lens wear during treatment and resume only after therapy completion. - Duration of therapy: limit use to the prescribed period to reduce risk of resistance and toxicity. - Systemic exposure: monitor patients with extensive ocular surface disease for signs of systemic absorption. - Pregnancy and lactation: consider potential risks and consult a healthcare professional before use. - Store at room temperature: keep in the original container, protect from light and moisture, and do not freeze.

Chloramphenicol ophthalmic can interact with certain systemic and topical agents; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Systemic chloramphenicol: concurrent use may increase risk of bone marrow suppression. - Anticoagulants (e.g., warfarin): may enhance anticoagulant effect, increasing bleeding risk. - Live vaccines: systemic absorption could theoretically diminish vaccine efficacy.

Moderate Interactions (Monitor Closely): - Other ophthalmic antibiotics: may cause additive ocular irritation. - Non‑steroidal anti‑inflammatory eye drops: monitor for increased local inflammation. - Topical corticosteroids: assess for delayed wound healing when combined.